Published in PLoS One on September 06, 2016
Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care (2010) 6.64
Common mechanisms of nerve and blood vessel wiring. Nature (2005) 5.46
EFNS guidelines on the use of skin biopsy in the diagnosis of peripheral neuropathy. Eur J Neurol (2005) 3.17
Surrogate markers of small fiber damage in human diabetic neuropathy. Diabetes (2007) 2.95
Abnormal lymphatic vessel development in neuropilin 2 mutant mice. Development (2002) 2.68
Skin denervation in type 2 diabetes: correlations with diabetic duration and functional impairments. Brain (2004) 2.45
Stabilization of HIF-1alpha is critical to improve wound healing in diabetic mice. Proc Natl Acad Sci U S A (2008) 2.07
The molecular basis for impaired hypoxia-induced VEGF expression in diabetic tissues. Proc Natl Acad Sci U S A (2009) 2.05
Role and therapeutic potential of VEGF in the nervous system. Physiol Rev (2009) 1.98
Topical capsaicin for pain management: therapeutic potential and mechanisms of action of the new high-concentration capsaicin 8% patch. Br J Anaesth (2011) 1.95
Peripheral nerve-derived VEGF promotes arterial differentiation via neuropilin 1-mediated positive feedback. Development (2005) 1.93
Systematic review of topical capsaicin for the treatment of chronic pain. BMJ (2004) 1.92
Mechanisms of vessel branching: filopodia on endothelial tip cells lead the way. Arterioscler Thromb Vasc Biol (2009) 1.91
Topical capsaicin in humans: parallel loss of epidermal nerve fibers and pain sensation. Pain (1999) 1.90
The time course of epidermal nerve fibre regeneration: studies in normal controls and in people with diabetes, with and without neuropathy. Brain (2004) 1.90
A role for axon guidance receptors and ligands in blood vessel development and tumor angiogenesis. Cytokine Growth Factor Rev (2005) 1.81
The neuropilins: multifunctional semaphorin and VEGF receptors that modulate axon guidance and angiogenesis. Trends Cardiovasc Med (2002) 1.70
Neurovascular factors in wound healing in the foot skin of type 2 diabetic subjects. Diabetes Care (2007) 1.66
Branching morphogenesis and antiangiogenesis candidates: tip cells lead the way. Nat Rev Clin Oncol (2009) 1.43
Small fiber neuropathy: A burning problem. Cleve Clin J Med (2009) 1.38
Intraepidermal nerve fiber density as a marker of early diabetic neuropathy. Muscle Nerve (2007) 1.30
Capsaicin induces degeneration of cutaneous autonomic nerve fibers. Ann Neurol (2010) 1.19
Neuropilin-1 mediates divergent R-Smad signaling and the myofibroblast phenotype. J Biol Chem (2010) 1.16
Tissue-specific regulation of microvascular diameter: opposite functional roles of neuronal and smooth muscle located vanilloid receptor-1. Mol Pharmacol (2008) 1.15
Evidence for a role of the chemorepellent semaphorin III and its receptor neuropilin-1 in the regeneration of primary olfactory axons. J Neurosci (1998) 1.14
Neuropilin-1 mediates PDGF stimulation of vascular smooth muscle cell migration and signalling via p130Cas. Biochem J (2011) 1.14
Immunolocalization and expression of vascular endothelial growth factor receptors (VEGFRs) and neuropilins (NRPs) on keratinocytes in human epidermis. Mol Med (2006) 1.09
Capsaicin-sensitive neurogenic sensory vasodilatation in the dura mater of the rat. J Physiol (2003) 1.07
Microvascular dysfunction in diabetic foot disease and ulceration. Diabetes Metab Res Rev (2009) 1.05
VEGF ligands and receptors: implications in neurodevelopment and neurodegeneration. Cell Mol Life Sci (2013) 1.05
Impaired neurovascular repair in subjects with diabetes following experimental intracutaneous axotomy. Brain (2011) 1.05
Asymptomatic small fiber neuropathy in diabetes mellitus: investigations with intraepidermal nerve fiber density, quantitative sensory testing and laser-evoked potentials. J Neurol (2011) 1.03
Dermal neurovascular dysfunction in type 2 diabetes. Diabetes Care (2001) 1.03
Mechanisms of distal axonal degeneration in peripheral neuropathies. Neurosci Lett (2015) 1.00
Painful diabetic neuropathy: diagnosis and management. Diabetes Metab (2011) 0.99
Reduced vascular endothelial growth factor expression and intra-epidermal nerve fiber loss in human diabetic neuropathy. Diabetes Care (2007) 0.98
Expression of semaphorin 3A and its receptors in the human intervertebral disc: potential role in regulating neural ingrowth in the degenerate intervertebral disc. Arthritis Res Ther (2010) 0.97
Semaphorin3A alleviates skin lesions and scratching behavior in NC/Nga mice, an atopic dermatitis model. J Invest Dermatol (2008) 0.97
The role of vascular endothelial growth factor in the progression of diabetic vascular complications. Eye (Lond) (2010) 0.96
Neuron restrictive silencer factor NRSF/REST is a transcriptional repressor of neuropilin-1 and diminishes the ability of semaphorin 3A to inhibit keratinocyte migration. J Biol Chem (2005) 0.93
Capsaicin causes protein synthesis inhibition and microtubule disassembly through TRPV1 activities both on the plasma membrane and intracellular membranes. Biochem Pharmacol (2007) 0.93
Dipeptidyl peptidase 4 inhibition may facilitate healing of chronic foot ulcers in patients with type 2 diabetes. Exp Diabetes Res (2012) 0.91
In vitro hepatic and skin metabolism of capsaicin. Drug Metab Dispos (2008) 0.90
The possible mechanisms underlying the impairment of HIF-1α pathway signaling in hyperglycemia and the beneficial effects of certain therapies. Int J Med Sci (2013) 0.90
Therapeutic potential of VEGF and VEGF-derived peptide in peripheral neuropathies. Neuroscience (2013) 0.90
A longitudinal study of sensory biomarkers of progression in patients with diabetic peripheral neuropathy using skin biopsies. J Clin Neurosci (2012) 0.89
Diabetic neuropathy and axon reflex-mediated neurogenic vasodilatation in type 1 diabetes. PLoS One (2012) 0.89
Decreased production of semaphorin 3A in the lesional skin of atopic dermatitis. Br J Dermatol (2008) 0.89
The time course of CO2 laser-evoked responses and of skin nerve fibre markers after topical capsaicin in human volunteers. Clin Neurophysiol (2010) 0.87
Factors influencing nerve regeneration in a trial of timcodar dimesylate. Neurology (2006) 0.87
Neuropilin-1 participates in wound angiogenesis. Am J Pathol (2002) 0.87
Prediabetes/early diabetes-associated neuropathy predominantly involves sensory small fibres. J Peripher Nerv Syst (2012) 0.86
Chemorepulsion and cell adhesion molecules in patterning initial trajectories of sensory axons. Neurosci Res (2005) 0.86
Functions of semaphorins in axon guidance and neuronal regeneration. Jpn J Pharmacol (2000) 0.84
Psoralen-ultraviolet A therapy alters epidermal Sema3A and NGF levels and modulates epidermal innervation in atopic dermatitis. J Dermatol Sci (2009) 0.84
Small fibre dysfunction, microvascular complications and glycaemic control in type 1 diabetes: a case-control study. Diabetologia (2011) 0.84
Small-fibre involvement in diabetic patients with neuropathic foot pain. Diabet Med (2008) 0.83
Antioxidant strategies in the management of diabetic neuropathy. Biomed Res Int (2015) 0.83
Decreased expression of semaphorin-3A, a neurite-collapsing factor, is associated with itch in psoriatic skin. Acta Derm Venereol (2012) 0.83
"Nocifensor" system re-revisited. Focus on "Two types of C nociceptor in human skin and their behavior in areas of capaicin-induced secondary hyperalgesia". J Neurophysiol (2004) 0.83
Epidermal expression of neuropilin 1 protects murine keratinocytes from UVB-induced apoptosis. PLoS One (2012) 0.82
NRP1 function and targeting in neurovascular development and eye disease. Prog Retin Eye Res (2016) 0.82
Pathways in the diagnosis and management of diabetic polyneuropathy. Curr Diab Rep (2015) 0.81
Diabetic neuropathies. Continuum (Minneap Minn) (2014) 0.80
Calcium signalling in sensory neurones and peripheral glia in the context of diabetic neuropathies. Cell Calcium (2014) 0.80
Neuropilin 1 expression correlates with differentiation status of epidermal cells and cutaneous squamous cell carcinomas. Lab Invest (2014) 0.79
Morphometric analysis of skin microvasculature in the diabetic foot. Singapore Med J (2008) 0.79
Pathogenesis of painful diabetic neuropathy. Pain Res Treat (2014) 0.78
Sema-3A indirectly disrupts the regeneration process of goldfish optic nerve after controlled injury. Graefes Arch Clin Exp Ophthalmol (2010) 0.77
Expression of Neuropeptides, Neurotrophins, and Neurotransmitters in the Skin of Patients with Atopic Dermatitis and Psoriasis. Bull Exp Biol Med (2015) 0.76